Literature DB >> 10821780

Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.

J Mialet1, Y Dahmoune, F Lezoualc'h, I Berque-Bestel, P Eftekhari, J Hoebeke, S Sicsic, M Langlois, R Fischmeister.   

Abstract

Among the five human 5-HT(4) (h5-HT(4)) receptor isoforms, the h5-HT(4(a)) receptor was studied with a particular emphasis on the molecular interactions involved in ligand binding. For this purpose, we used site-directed mutagenesis of the transmembrane domain. Twelve mutants were constructed with a special focus on the residue P4.53 of helix IV which substitutes in h5-HT(4) receptors the highly conserved S residue among the rhodopsin family receptors. The mutated receptors were transiently expressed in COS-7 cells. Ligand binding or competition studies with two h5-HT(4) receptor agonists, serotonin and ML10302 and two h5-HT(4) receptor antagonists, [(3)H]-GR113808 and ML10375 were performed on wild type and mutant receptors. Functional activity of the receptors was evaluated by measuring the ability of serotonin to stimulate adenylyl cyclase. Ligand binding experiments revealed that [(3)H]-GR113808 did not bind to mutants P4.53A, S5.43A, F6.51A, Y7.43A and to double mutant F6.52V/N6.55L. On the other hand mutations D3.32N, S5.43A and Y7.43A appeared to promote a dramatic decrease of h5-HT(4(a)) receptor functional activity. From these studies, S5.43 and Y7.43 clearly emerged as common anchoring sites to antagonist [(3)H]-GR113808 and to serotonin. According to these results, we propose ligand-receptor complex models with serotonin and [(3)H]-GR113808. For serotonin, three interaction points were selected including ionic interaction with D3.32, a stabilizing interaction of this ion pair by Y7.43 and a hydrogen bond with S5.43. [(3)H]-GR113808 was also docked, based on the same type of interactions with S5.43 and D3.32: the proposed model suggested a possible role of P4.53 in helix IV structure allowing the involvement of a close hydrophobic residue, W4.50, in a hydrophobic pocket for hydrophobic interactions with the indole ring of [(3)H]-GR113808.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821780      PMCID: PMC1572113          DOI: 10.1038/sj.bjp.0703356

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors.

Authors:  B L Roth; M Shoham; M S Choudhary; N Khan
Journal:  Mol Pharmacol       Date:  1997-08       Impact factor: 4.436

2.  Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.

Authors:  S Trumpp-Kallmeyer; J Hoflack; A Bruinvels; M Hibert
Journal:  J Med Chem       Date:  1992-09-18       Impact factor: 7.446

3.  Purification of plasma membranes by aqueous two-phase affinity partitioning.

Authors:  A Persson; B Jergil
Journal:  Anal Biochem       Date:  1992-07       Impact factor: 3.365

Review 4.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

5.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors.

Authors:  J M Baldwin; G F Schertler; V M Unger
Journal:  J Mol Biol       Date:  1997-09-12       Impact factor: 5.469

Review 6.  Structure and function of receptors coupled to G proteins.

Authors:  J M Baldwin
Journal:  Curr Opin Cell Biol       Date:  1994-04       Impact factor: 8.382

7.  Amino acids of the alpha1B-adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes.

Authors:  A Cavalli; F Fanelli; C Taddei; P G De Benedetti; S Cotecchia
Journal:  FEBS Lett       Date:  1996-12-09       Impact factor: 4.124

8.  Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.

Authors:  N Almaula; B J Ebersole; J A Ballesteros; H Weinstein; S C Sealfon
Journal:  Mol Pharmacol       Date:  1996-07       Impact factor: 4.436

9.  Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.

Authors:  C D Wang; T K Gallaher; J C Shih
Journal:  Mol Pharmacol       Date:  1993-06       Impact factor: 4.436

Review 10.  Do human atrial 5-HT4 receptors mediate arrhythmias?

Authors:  A J Kaumann
Journal:  Trends Pharmacol Sci       Date:  1994-12       Impact factor: 14.819

View more
  12 in total

1.  G protein-coupled receptors: in silico drug discovery in 3D.

Authors:  Oren M Becker; Yael Marantz; Sharon Shacham; Boaz Inbal; Alexander Heifetz; Ori Kalid; Shay Bar-Haim; Dora Warshaviak; Merav Fichman; Silvia Noiman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Computational model of the complex between GR113808 and the 5-HT4 receptor guided by site-directed mutagenesis and the crystal structure of rhodopsin.

Authors:  M L López-Rodríguez; M Murcia; B Benhamú; M Olivella; M Campillo; L Pardo
Journal:  J Comput Aided Mol Des       Date:  2001-11       Impact factor: 3.686

4.  5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.

Authors:  M Cachard-Chastel; F Lezoualc'h; I Dewachter; C Deloménie; S Croes; H Devijver; M Langlois; F Van Leuven; S Sicsic; A M Gardier
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

5.  New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket.

Authors:  Lucie Rivail; Mireille Giner; Monique Gastineau; Magali Berthouze; Jean-Louis Soulier; Rodolphe Fischmeister; Frank Lezoualc'h; Bernard Maigret; Sames Sicsic; Isabelle Berque-Bestel
Journal:  Br J Pharmacol       Date:  2004-09-06       Impact factor: 8.739

6.  Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.

Authors:  Thibault Varin; Hugo Gutiérrez-de-Terán; Marián Castro; José Brea; Frederic Fabis; François Dauphin; Johan Aqvist; Alban Lepailleur; Pilar Perez; Javier Burgueño; José Miguel Vela; Maria Isabel Loza; Jordi Rodrigo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

7.  A hybrid structural approach to analyze ligand binding by the serotonin type 4 receptor (5-HT4).

Authors:  Pius S Padayatti; Liwen Wang; Sayan Gupta; Tivadar Orban; Wenyu Sun; David Salom; Steven R Jordan; Krzysztof Palczewski; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2013-02-01       Impact factor: 5.911

8.  Benzimidazole derivatives. 4. The recognition of the voluminous substituent attached to the basic amino group of 5-HT4 receptor antagonists.

Authors:  Maria L López-Rodríguez; Bellinda Benhamú; Marta Murcia; Elsa Alvaro; Mercedes Campillo; Leonardo Pardo
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

9.  Identification of essential residues for binding and activation in the human 5-HT7(a) serotonin receptor by molecular modeling and site-directed mutagenesis.

Authors:  Agata Antonina Rita Impellizzeri; Matteo Pappalardo; Livia Basile; Ornella Manfra; Kjetil Wessel Andressen; Kurt Allen Krobert; Angela Messina; Finn Olav Levy; Salvatore Guccione
Journal:  Front Behav Neurosci       Date:  2015-05-08       Impact factor: 3.558

Review 10.  Homology models of melatonin receptors: challenges and recent advances.

Authors:  Daniele Pala; Alessio Lodola; Annalida Bedini; Gilberto Spadoni; Silvia Rivara
Journal:  Int J Mol Sci       Date:  2013-04-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.